Pancreatic Cancer Europe is a legal entity (ASBL) since 2016 registered in Brussels - Belgium, under the number ASBL n°656.553.804. All decisions regarding the platform are taken collectively by platform members, each of them having an equal voice in the decisions regarding the platform’s activities and orientations.

Our administration board:

 

Alfredo Carrato

Professor of Medical Oncology at Alcala University and Director of the Medical Oncology Department at Ramon y Cajal University Hospital in Madrid, Spain. He is presently serving as Director of the Ramon y Cajal Institute for Health Research IRYCIS.

 

Ali Stunt

Diagnosed in 2007, Ali Stunt is one of the few pancreatic cancer surviving patients. Saved by an early diagnosis of the disease, Ali is the Founder and Chief Executive of Pancreatic Cancer Action (UK), an association devoted to encourage early diagnosis for the illness.

 

Lydia Makaroff

Director of the European Cancer Patient Coalition (ECPC)

 

 

 

Dr. Núria Malats

Dr. Núria Malats is currently the head of the Genetic and Molecular Epidemiology Group at the Spanish National Cancer Research Centre (CNIO), Madrid, Spain. She has a broad expertise in these fields of research by focusing mainly on bladder and pancreas cancer. She coordinates several large national and international studies integrating different levels of information, including omics data, in both disease development and progression. She has over 250 publications and is external reviewer of national and international funding agencies and first rank scientific journals. Dr. Malats chaired the EUPancreas COST Action (BM1204), is a board member of the International Pancreatic Cancer Case Control Consortium (PanC4), and the chair of the Research Work Stream of Pancreatic Cancer Europe (PCE) multistakeholder platform.